The Proposed Usage of Intranasal Steroids and Antihistamines for Otitis Media with Effusion
- 52 Downloads
Purpose of Review
To examine the role of allergy medications in the treatment of otitis media with effusion (OME), focusing on use of intranasal steroids and antihistamines.
There has been ongoing controversy regarding the role of allergy in the development of OME. Treatment of OME with medications commonly used for allergic symptomatology has been studied. Proposed treatment options include decongestants, mucolytics, oral steroids, topical steroids, antihistamines, and antibiotics. We begin by evaluating the proposed association between allergy and OME, and then evaluate intranasal steroids and oral antihistamine therapy in the treatment of OME. The role of the adenoid and concurrent nasal symptomatology is also addressed.
The preponderance of data suggests that neither intranasal steroids nor antihistamines improve the long-term clearance of isolated OME and are therefore not recommended. However, data are notably limited with regard to improvement rates in OME in patients specifically with concurrent allergy and/or adenoid hypertrophy. Future studies of medications for OME would ideally incorporate study designs controlling for both allergic rhinitis and adenoid hypertrophy, to better understand the impact of these medications on OME in these subgroups of patients.
KeywordsOtitis media with effusion Eustachian tube dysfunction Allergic rhinitis Antihistamines Intranasal steroids Adenoid
Compliance with Ethical Standards
Conflict of Interest
RER is a consultant for Roche Genentech, Gossamer Bio, and Syneos Health. DSC has no disclosures. JJS receives textbook royalties from Evidence-Based Otolaryngology, Shin JJ, Randolph GW, editors; New York: Springer, 2008, and from Otolaryngology Prep and Practice. Shin JJ, Cunningham MJ, editors; Plural Publishing, 2013. JJS is also a recipient of the American Academy of the Otolaryngology-Head and Neck Surgery Foundation Maureen Hannley grant, the Brigham Care Redesign Program Award, and the Schlager Family Innovations Fund Award.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 1.Allergies | Gateway to Health Communication | CDC. https://www.cdc.gov/healthcommunication/ToolsTemplates/EntertainmentEd/Tips/Allergies.html. Accessed 30 Jul 2018.
- 6.•• Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis: ICAR: allergic rhinitis. Int Forum of Allergy Rhinol. 2018;8:108–352 COMMENT: excellent overview of clinical practice guidelines for allergic rhinitis and its treatment. Google Scholar
- 8.Rosenfeld RM, Shin JJ. Clinical Practice Guideline. Head Neck Surg 14.Google Scholar
- 12.Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2011:CD001935.Google Scholar
- 13.Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD003423.pub3.
- 16.Lewis ER. Otitis media and allergy. Ann Otol Rhin Laryng. 1929;38.Google Scholar
- 28.Butler CC, Van Der Voort JH. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2002:CD001935.Google Scholar
- 38.Akyol MU, Cengel S (2006) The role of topical nasal steroid aerosol treatment in children with otitis media with effusion and/or adenoid hypertrophy. 12 months follow up.Google Scholar
- 41.van den Aardweg MT, Schilder AG, Herkert E, Boonacker CW, Rovers MM. Adenoidectomy for otitis media in children. Cochrane Database Syst Rev. 2010:CD007810.Google Scholar
- 42.van den Aardweg MT, Schilder AG, Herkert E, Boonacker CW, Rovers MM. Adenoidectomy for recurrent or chronic nasal symptoms in children. Cochrane Database Syst Rev. 2010:CD008282.Google Scholar
- 43.Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, et al. A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care. Health Technol Assess. 2009;13:1–144.CrossRefPubMedGoogle Scholar
- 44.Williamson I. Otitis media with effusion in children. BMJ Clin Evid. 2011;2011.Google Scholar
- 47.Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, et al. Otitis media with effusion: comparative effectiveness of treatments. Rockville: Agency for Healthcare Research and Quality (US); 2013.Google Scholar
- 54.Coleman C, Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2008:CD001727.Google Scholar
- 57.Griffin G, Flynn CA, Bailey RE, Schultz JK. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2006. https://doi.org/10.1002/14651858.CD003423.pub2.
- 58.Mb AGB, Frcpc RDG Antihistamines for children with otitis media. 3.Google Scholar
- 61.•• Wang DE, Lam DJ, Bellmunt AM, Rosenfeld RM, Ikeda AK, Shin JJ. Intranasal steroid use for otitis media with effusion: ongoing opportunities for quality improvement. Otolaryngology-Head Neck Surg. 2017;157:289–96 COMMENT: Study showing that despite randomized controlled trials showing lack of efficacy of intranasal steroids for treatment of OME, this treatment strategy is still commonly used in the US. CrossRefGoogle Scholar
- 64.•• McCoul ED, Weinreich HM, Mulder H, Man L-X, Schulz K, Shin JJ. Health care utilization and prescribing patterns for adult Eustachian tube dysfunction. Otolaryngology–Head Neck Surg. 2019:019459981982695 COMMENT: Study evaluating practice patterns and epidemiologic data in the treatment of eustachian tube dysfunction in adults. Google Scholar